- Home
- SONN vs ICCT Comparison
SONN vs ICCT Comparison
Compare SONN & ICCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- ICCT
- Stock Information
- Founded
- SONN N/A
- ICCT 1992
- Country
- SONN United States
- ICCT United States
- Employees
- SONN N/A
- ICCT N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- ICCT Computer Software: Prepackaged Software
- Sector
- SONN Health Care
- ICCT Technology
- Exchange
- SONN Nasdaq
- ICCT Nasdaq
- Market Cap
- SONN 4.6M
- ICCT 6.7M
- IPO Year
- SONN N/A
- ICCT N/A
- Fundamental
- Price
- SONN $1.29
- ICCT $1.96
- Analyst Decision
- SONN Strong Buy
- ICCT
- Analyst Count
- SONN 2
- ICCT 0
- Target Price
- SONN $38.00
- ICCT N/A
- AVG Volume (30 Days)
- SONN 31.6K
- ICCT 3.4M
- Earning Date
- SONN 05-16-2025
- ICCT 05-14-2025
- Dividend Yield
- SONN N/A
- ICCT N/A
- EPS Growth
- SONN N/A
- ICCT N/A
- EPS
- SONN N/A
- ICCT N/A
- Revenue
- SONN $1,000,000.00
- ICCT $11,049,477.00
- Revenue This Year
- SONN $5,376.22
- ICCT N/A
- Revenue Next Year
- SONN N/A
- ICCT N/A
- P/E Ratio
- SONN N/A
- ICCT N/A
- Revenue Growth
- SONN 674.14
- ICCT 42.66
- 52 Week Low
- SONN $1.10
- ICCT $0.24
- 52 Week High
- SONN $16.00
- ICCT $27.80
- Technical
- Relative Strength Index (RSI)
- SONN 45.29
- ICCT 45.12
- Support Level
- SONN $1.30
- ICCT $2.00
- Resistance Level
- SONN $1.37
- ICCT $2.55
- Average True Range (ATR)
- SONN 0.10
- ICCT 0.46
- MACD
- SONN -0.01
- ICCT -0.13
- Stochastic Oscillator
- SONN 22.58
- ICCT 6.94
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About ICCT iCoreConnect Inc. Common stock
iCoreConnect Inc develops and markets secure cloud-based HIPAA compliant software services focused on compliance, workflow/productivity, and electronic health records systems. Its core services technology can be adopted to other vertical markets that require a high degree of secure data communication, such as the legal, financial, and education fields. It markets secure HIPAA compliant cloud-based software as a service (SaaS) offering under the names of iCoreExchange, iCoreCodeGenius, iCoreSecure, iCoreMD, iCoreDental, iCoreMobile, iCoreHuddle, iCoreRx, iCorePDMP, iCoreEPCS, and iCorePay. The company's software is sold under annual recurring revenue subscriptions. The company has a single reporting segment for reporting purposes focused on the North American market.